Calcium Hydroxylapatite (CaHA) and Aesthetic Outcomes: A Systematic Review of Controlled Clinical Trials
Journal of Clinical Medicine · 14.03.2024 · 13 (6) · 1686
DOI: 10.3390/jcm13061686 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 14.03.2024. Verfasst von Mojgan Amiri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Epistudia, 3008 Bern, Switzerland. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSRD VA, Merz North America, Inc..
Abstract (Originalsprache)
Background
This study aimed to systematically review and summarize the available controlled clinical trials on the effectiveness of calcium hydroxylapatite (CaHA) in terms of aesthetic outcomes, skin-aging-related outcomes, and patient/investigator satisfaction.
Methods
We included controlled clinical trials involving at least 10 human adults that examined the effects of CaHA on aesthetic and skin-aging-related outcomes and satisfaction. Due to the high heterogeneity among the included studies, only a qualitative analysis is provided.
Results
Out of 2935 relevant references, 13 studies were included, of which 8 studies focused on facial areas and 5 on dorsum of hand. CaHA injection was associated with enhancements in global aesthetic improvement scale, whether applied in facial regions or on the dorsum of hands. The findings suggested high patients’ satisfaction following CaHA when applied to facial areas. Studies highlighted improvements in hand grading scales and a reduction in facial wrinkles.
Conclusions
Current evidence suggests that CaHA injections improve aesthetic results, including facial areas, such as nasolabial folds and jawline, and hands, with high levels of satisfaction. Considering the methodological limitations and heterogeneous comparisons groups, additional controlled clinical trials would contribute to a better understanding of the applications and advantages offered by CaHA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Epistudia, 3008 Bern, Switzerland.
- Department of Endocrinology and Diabetology, Medical University of Graz, 8010 Graz, Austria.
- Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, 14558 Nuthetal, Germany.
- German Center for Diabetes Research (DZD), 85764 München-Neuherberg, Germany.
- Literature Searches Support, 3314 SC Dordrecht, The Netherlands.
- Merz North America, Inc., Raleigh, NC 27615, USA.
ORCID-Profile: Erand Llanaj, Christa D Niehot, Taulant Muka
Förderung
- CSRD VA
- Merz North America, Inc.
Zitieren
APA
Amiri, M., Meçani, R., Llanaj, E., Niehot, C. D., Phillips, T. L., Goldie, K., Kolb, J., Muka, T., & Daughtry, H. (2024). Calcium Hydroxylapatite (CaHA) and Aesthetic Outcomes: A Systematic Review of Controlled Clinical Trials. Journal of Clinical Medicine, 13(6), 1686. https://doi.org/10.3390/jcm13061686
Vancouver
Amiri M, Meçani R, Llanaj E, Niehot CD, Phillips TL, Goldie K, et al. Calcium Hydroxylapatite (CaHA) and Aesthetic Outcomes: A Systematic Review of Controlled Clinical Trials. Journal of Clinical Medicine. 2024;13(6):1686. doi:10.3390/jcm13061686
BibTeX
@article{Amiri2024,
author = {Amiri, Mojgan and Meçani, Renald and Llanaj, Erand and Niehot, Christa D and Phillips, Terri L and Goldie, Katherine and Kolb, Janina and Muka, Taulant and Daughtry, Hua},
title = {Calcium Hydroxylapatite (CaHA) and Aesthetic Outcomes: A Systematic Review of Controlled Clinical Trials},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {6},
pages = {1686},
doi = {10.3390/jcm13061686}
}
EUVIMED